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Traffic Marker?
Early Exposure to Air Pollution Associated with 
Childhood Asthma
Asthma is now the most common chronic disease for children and 
a major cause of emergency room visits, hospitalizations, and school 
absences, according to the World Health Organization. Now a large 
population-based study has shown an association between elevated 
exposure to air pollution in utero and during the first year of life and a 
higher risk of asthma in preschool-aged children [EHP 118:284–290; 
Clark et al.]. 
There are multiple known risk factors for developing asthma, 
including genetic factors, diet, and exposure to secondhand tobacco 
smoke and allergens. The speed with which the disease has risen in 
most developed and developing countries suggests environmental 
exposures probably play a prominent role. Although air pollution is 
known to worsen existing asthma, a succession of recent studies is 
building evidence for an additional association between exposure to 
traffic-related air pollution and initial onset of asthma in children.
Using a nested case–control study design, researchers looked at 
administrative and health care data for nearly 3,500 children born in 
southwest British Columbia, Canada, in 1999 and 2000 who were 
diagnosed with asthma by age 4 years. Each case was age- and sex-
matched to 5 randomly chosen controls born in the same region and 
time period. 
To estimate air pollutant exposures, the researchers mapped the 
residential history of each child against air pollution data obtained 
from regulatory monitoring, land use regression modeling, and prox-
imity to stationary pollution sources and to roads. These metrics were 
used to calculate average exposures for the duration of the mother’s 
pregnancy and the child’s first year of life. Nine pollutant exposures 
were evaluated: carbon monoxide, nitric oxide, nitrogen dioxide, par-
ticulate matter (PM10 and PM2.5), ozone, sulfur dioxide, black carbon, 
and wood smoke.
The highest risk of asthma was associated with exposure to the 
traffic-related pollutants carbon monoxide, nitric oxide, nitrogen 
dioxide, and black carbon; lesser associations were seen with exposure 
to PM10 and sulfur dioxide, as well as with proximity to industrial 
point sources. Proximity to roads was not associated with increased 
risk, but only a small number of children resided near major roads in 
the study population. Associations between air pollution and asthma 
were generally greater in girls than in boys, although asthma was sig-
nificantly more common in boys, consistent with other populations. 
The authors observe that other researchers also have reported stronger 
associations in girls, although the finding is not entirely consistent. 
This is one of the few studies to examine the effect of in utero 
exposure on pediatric asthma risk. However, because of relatively 
high correlation between in utero and first-year exposures, the relative 
importance of these periods could not be discerned. 
Laura Alderson has written for EHP since the 1990s. She is a freelance writer based in Raleigh, 
North Carolina, specializing in medicine, science, and high technology.
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Running Phthalates to Ground
Pinpointing Exposure Sources in a Virtual Home
Methods  to  measure  concentrations  of  chemicals  in  adults  and 
children,  a  science  known  as  biomonitoring,  can  be  costly  and 
burdensome.  And,  although  biomonitoring  data  provide  useful 
aggregate  information  on  exposure  to  all  sources,  it  is  almost 
impossible to tell how much comes from a specific source. A new 
mechanistic  model  may  offer  a  way  to 
identify  the  strongest  sources  of  exposure 
to  semivolatile  organic  compounds  by 
showing how chemicals move from a single 
product through a home and which model 
parameters  have  the  greatest  influence  on 
exposure [EHP 118:253–258; Xu et al.].
Researchers created a model of a hypo-
thetical  three-room  house  equipped  with 
adjustable airflow systems to illustrate how 
human  exposure  to  phthalates  released 
by  a  specific  source—in  this  case,  vinyl 
flooring—might  be  predicted.  Phthalates 
are plasticizers that are used in products as 
diverse  as  nail  polish,  plastic  wiring,  and 
children’s toys. Data from the Centers for 
Disease  Control  and  Prevention  suggest 
that  more  than  three-quarters  of  the 
U.S. population may be exposed to these 
suspected endocrine disruptors.
The  research  team  built  on  an  earlier 
m o d e l  t h a t  d e s c r i b e d  h o w  d i e t h y l h e x y l  
phthalate (DEHP)—one of the most prevalent 
phthalates—is  released  from  vinyl  flooring 
into air and sorbs strongly to interior surfaces 
(walls,  ceilings,  floors,  furniture,  etc.)  and 
suspended particles. Here the researchers used 
the model to explore the relative importance of inhalation of vapor, 
inhalation of particles, dermal sorption of DEHP, and oral ingestion 
of household dust on total exposure levels. To test which parameters 
might change the amount of total DEHP exposure through different 
routes, the researchers varied model parameters such as the amount of 
ventilation and velocity of air moving through their model house.
For example, they calculated that a fan pushing air through 
the  house  would  cause  more  skin  contact  with  phthalates  by 
increasing the release rate from the vinyl surfaces to the air. The 
fan also thinned the layer of air cushioning 
the skin, increasing the transfer of DEHP 
from air to skin. Stagnant air without the 
fan caused less transfer of DEHP from air to 
skin, thus protecting against dermal uptake 
of DEHP.
The new model suggests that levels of 
phthalates measured in adults and children 
may result in part from contact with surfaces 
that  may  absorb  high  concentrations  of 
DEHP,  such  as  clothing.  Changing  the 
variables in the model house—from airflow 
to  the  amount  of  DEHP  in  the  vinyl 
flooring to square footage in a room—made 
a  difference  in  estimated  exposure  levels. 
Varying the parameters in this simple model 
demonstrated  the  potential  for  DEHP 
exposures  arising  from  a  single  product 
to  differ  by  as  much  as  40  times  from 
one  situation  to  another.  That  variability 
underscores  the  wide  range  of  possible 
exposures  across  the  population—and  the 
difficulty of relying on biomonitoring alone 
to identify the most harmful sources.
Naomi Lubick is a freelance science writer based in Zürich, 
Switzerland, and Folsom, California. She has written for 
Environmental Science & Technology, Nature, and Earth.
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Exposure to gas-phase phthalates 
from vinyl flooring can occur 
through ingestion, inhalation, or 
dermal absorption.To Each His Own
DEHP Yields Species-Specific Metabolic 
Phenotypes
Endocrine disruptors have been shown to disturb the balance between 
energy expenditure and storage in cellular models, a balance that is 
critical for proper metabolic functioning. Peroxisome proliferator–
activated receptors (PPARs), potential molecular targets of endocrine 
disruptors in several tissues and organs, hold a key position as lipid 
sensors that direct metabolic gene expression. A new mouse study 
illustrates activation of a specific PPAR isotype with exposure to the 
endocrine disruptor diethylhexyl phthalate (DEHP) and provides evi-
dence that the potential influence of DEHP exposure on diet-induced 
obesity may vary between species [EHP 118:234–241; Feige et al.].
DEHP is a widely used industrial plasticizer that can leach from 
diverse consumer products including food packaging and medical 
devices such as plastic tubing and bags. When ingested, DEHP is 
converted to monoethylhexyl phthalate (MEHP), which is readily 
absorbed. Previous in vitro research has demonstrated that MEHP 
can activate all three PPAR isotypes (PPARα, PPARβ, and PPARγ). 
The result in vivo can be opposing effects depending on which iso-
type is activated: induction of adipogenesis (PPARγ) or fatty acid 
oxidation (PPARα, PPARβ).
To determine the physical and biochemical effects of DEHP 
exposure, weanling mice were fed regular diets, with treatment 
groups receiving either 100 mg DEHP/kg/day (low dose) or 1,000 
mg DEHP/kg/day (high dose) in the chow. Food intake and physical 
activity did not differ between groups, and lean body mass was not 
affected. However, in DEHP-treated mice fat reserves were reduced, 
and blood tests indicated increased hepatic fatty acid oxidation. As a 
result, mice in the high-dose group gained 15% less weight than low-
dose and control mice over the 10-week treatment period. 
In a separate experiment, adult mice were fed a high-fat diet for 
13 weeks. Fat mass increased from a baseline 8–10% of body mass to 
30% in untreated mice but remained unchanged in mice receiving 
500 mg DEHP/kg/day. Further experiments investigating the pattern 
of PPAR target gene expression and using mice lacking either PPARα 
or PPARβ revealed that DEHP effects were mediated through 
PPARα in the liver. 
Finally, to make the model more applicable to humans, mice 
genetically engineered to carry human PPARα were exposed to 
DEHP. Interestingly, MEHP did not protect these mice from diet-
related obesity as it did in wild-type mice; in fact, MEHP led to 
these mice being even more obese than controls. If this relationship 
holds true in humans, exposure to certain endocrine disruptors could 
potentially contribute to obesity by promoting fat accumulation.
Conclusions drawn from this study include the identification 
of hepatic PPARα as a key site for DEHP-associated disruption. 
The doses applied in this study are 2–3 orders of magnitude higher 
than estimated typical human exposures when normalized to body 
mass. However, the observation of subtle, species-specific differences 
in metabolic response to DEHP point to an important factor that 
should be considered as the biological effects of DEHP on human 
health are further explored. 
Julia R. Barrett, MS, ELS, a Madison, Wisconsin–based science writer and editor, has written 
for EHP since 1996. She is a member of the National Association of Science Writers and the Board 
of Editors in the Life Sciences.
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PFCs and Cholesterol 
A Sticky Connection
Polyfluoroalkyl chemicals (PFCs), highly stable compounds used in 
consumer items such as food packaging, textiles, and paper products, 
are known to migrate throughout and persist in the environment. 
Animal studies have described the development of adverse health 
effects such as tumors and developmental delays with exposure to the 
PFCs perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic 
acid (PFOS). A new study now suggests these and other PFCs may 
affect serum cholesterol levels in humans 
[EHP 118:197–202; Nelson et al.].
Elevated cholesterol levels are associat-
ed with an increased risk of cardio  vascular 
disease, and are one of the conditions 
that define metabolic syndrome. Risk 
factors for high cholesterol include diet, 
low physical activity, and a family history 
of the condition, but increasing evidence 
indicates some environmental chemicals 
also may contribute. With estimated half-
lives of up to 8.5 years, PFCs are classified 
as persistent organic pollutants (POPs). 
However, unlike most POPs, which are 
stored primarily in fat tissue, PFCs persist 
by forming chemical bonds to proteins in 
the liver and serum. 
Previous studies in humans have 
reported positive associations between 
PFOS and PFOA exposures and high-
er cholesterol levels. The research team 
in the current study investigated the 
relationship between insulin resistance, 
cholesterol levels, body size, and exposure to two less studied PFCs, 
perfluorononanoic acid (PFNA), and perfluorohexane sulfonic acid 
(PFHxS) in addition to PFOS and PFOA. The study used data from 
the 2003–2004 National Health and Nutrition Examination Survey.
The authors found a positive association between total cho-
lesterol (TC) and serum concentrations of PFOS, PFOA, and 
PFNA. TC is the sum of low-density and very low-density lipo-
proteins (“bad” cholesterol) and high-density lipoproteins (“good” 
cholesterol). The findings appeared driven by an increase in the 
non–high-density lipoprotein fraction of TC, and the association 
was most pronounced for PFNA. In 
contrast, PFHxS concentrations were 
inversely related to TC: samples reflect-
ing the highest PFHxS exposure had the 
lowest TC levels. 
The authors observed little evidence 
of associations between body size, insu-
lin resistance, and PFC concentrations. 
They note several limitations in this 
study, including the fact they could 
not rule out the possibility of reverse 
causality—that is, that having higher 
cholesterol levels could lead to increased 
PFC  concentrations  in  the  blood. 
Nevertheless, the results support previ-
ous epidemiologic research indicating 
that environmentally relevant exposures 
to PFCs may affect human cholesterol 
metabolism or homeostasis. 
Tanya Tillett, MA, of Durham, North Carolina, is a staff 
writer/editor for EHP. She has been on the EHP staff since 
2000 and has represented the journal at national and 
international conferences. 
Certain environmental 
chemicals may be a risk 
factor for high cholesterol.